Author Edelmann, Frank
-
2023 | Journal Article |
Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial
Wilke, M. R.; Broschmann, D.; Sandek, A.; Wachter, R.; Edelmann, F. & Herrmann‐Lingen, C. (2023)
BMC Cardiovascular Disorders, 23(1) art. 184. DOI: https://doi.org/10.1186/s12872-023-03136-8
Details DOI
-
2023 | Journal Article |
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial
Lechner, K.; Bock, M.; von Schacky, C.; Scherr, J.; Lorenz, E.; Lechner, B. & Haller, B. et al. (2023)
Clinical Research in Cardiology,. DOI: https://doi.org/10.1007/s00392-022-02143-7
Details DOI
-
2023 | Journal Article
De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients
Bock, M.; von Schacky, C.; Scherr, J.; Lorenz, E.; Lechner, B.; Krannich, A. & Wachter, R. et al. (2023)
Journal of Clinical Medicine, 12(15) pp. 4938. DOI: https://doi.org/10.3390/jcm12154938
Details DOI
-
2023 | Journal Article
Repurposing the β 3 -Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease
Balligand, J.-L.; Brito, D.; Brosteanu, O.; Casadei, B.; Depoix, C.; Edelmann, F. & Ferreira, V. et al. (2023)
JAMA Cardiology,. DOI: https://doi.org/10.1001/jamacardio.2023.3003
Details DOI
-
2023 | Journal Article
Supervised exercise training in patients with advanced heart failure and left ventricular assist device: A multicentre randomized controlled trial ( Ex‐VAD trial)
Feuerstein, A.; Schoenrath, F.; Belyavskiy, E.; Knierim, J.; Friede, T.; Placzek, M. & Bach, D. et al. (2023)
European Journal of Heart Failure, art. ejhf.3032. DOI: https://doi.org/10.1002/ejhf.3032
Details DOI
-
2023 | Journal Article
Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz (Teil 3)
von Haehling, S.; Arzt, M.; Doehner, W.; Edelmann, F.; Evertz, R.; Ebner, N. & Herrmann-Lingen, C. et al. (2023)
Die Kardiologie, 17(1) pp. 50-62. DOI: https://doi.org/10.1007/s12181-023-00593-5
Details DOI
-
2023 | Journal Article
Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials
Kresoja, K.-P.; Unterhuber, M.; Wachter, R.; Rommel, K.-P.; Besler, C.; Shah, S. & Thiele, H. et al. (2023)
EBioMedicine, 96 art. 104795. DOI: https://doi.org/10.1016/j.ebiom.2023.104795
Details DOI
-
2022 | Journal Article |
Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study
Eidizadeh, A.; Schnelle, M.; Leha, A.; Edelmann, F.; Nolte, K.; Werhahn, S. M. & Binder, L. et al. (2022)
ESC Heart Failure, 10(1) art. ehf2.14167. DOI: https://doi.org/10.1002/ehf2.14167
Details DOI
-
2022 | Journal Article
Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
Hashemi, D.; Mende, M.; Trippel, T. D.; Petutschnigg, J.; Hasenfuss, G.; Nolte, K. & Herrmann‐Lingen, C. et al. (2022)
ESC Heart Failure, 9(6) art. ehf2.14131. DOI: https://doi.org/10.1002/ehf2.14131
Details DOI
-
2022 | Journal Article
Movement therapy in lung transplantation candidates assisted by a lightweight wearable robot
Just, I. A.; Fries, D.; Loewe, S.; Falk, V.; Cesarovic, N.; Kemper, D. & Edelmann, F. et al. (2022)
Assistive Technology,. DOI: https://doi.org/10.1080/10400435.2022.2067914
Details DOI
-
2022 | Journal Article
Movement therapy in advanced heart failure assisted by a lightweight wearable robot: a feasibility pilot study
Just, I. A.; Fries, D.; Loewe, S.; Falk, V.; Cesarovic, N.; Edelmann, F. & Feuerstein, A. et al. (2022)
ESC Heart Failure,. DOI: https://doi.org/10.1002/ehf2.13903
Details DOI
-
2022 | Journal Article |
Glucose-Induced Hemodynamic and Metabolic Response of Skeletal Muscle in Heart Failure Patients with Reduced vs. Preserved Ejection Fraction—A Pilot Study
Boschmann, M.; Klug, L.; Edelmann, F.; Sandek, A.; von Haehling, S.; Düngen, H.-D. & Springer, J. et al. (2022)
Journal of Cardiovascular Development and Disease, 9(12) pp. 456. DOI: https://doi.org/10.3390/jcdd9120456
Details DOI
-
2022 | Journal Article |
Comorbidities in heart failure with preserved ejection fraction
Deichl, A.; Wachter, R. & Edelmann, F. (2022)
Herz,. DOI: https://doi.org/10.1007/s00059-022-05123-9
Details DOI
-
2022 | Journal Article
Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz
von Haehling, S.; Arzt, M.; Doehner, W.; Edelmann, F.; Evertz, R.; Ebner, N. & Herrmann-Lingen, C. et al. (2022)
Der Kardiologe, 16(2) pp. 185-196. DOI: https://doi.org/10.1007/s12181-022-00537-5
Details DOI
-
2022 | Journal Article
Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz (Teil 2)
von Haehling, S.; Arzt, M.; Doehner, W.; Edelmann, F.; Evertz, R.; Ebner, N. & Herrmann-Lingen, C. et al. (2022)
Die Kardiologie,. DOI: https://doi.org/10.1007/s12181-022-00574-0
Details DOI
-
2021 | Journal Article | Research Paper
Die Bedeutung gesundheitsbezogener Lebensqualität für die Vorhersage des ereignisfreien Überlebens bei Patienten mit kardiovaskulärem Risikoprofil
Beismann, C.; Nolte, K.; Wachter, R.; Hashemi, D.; Trippel, T.; Edelmann, F. & Meyer, T. (2021)
Zeitschrift für psychosomatische Medizin und Psychotherapie, 67(4) pp. 361-380. DOI: https://doi.org/10.13109/zptm.2021.67.4.361
Details DOI PMID PMC
-
2021 | Journal Article |
Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial
Lechner, K.; Scherr, J.; Lorenz, E.; Lechner, B.; Haller, B.; Krannich, A. & Halle, M. et al. (2021)
Clinical Research in Cardiology, 111(3) pp. 308-321. DOI: https://doi.org/10.1007/s00392-021-01925-9
Details DOI
-
2021 | Journal Article
Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction
Fitz, J.; Edelmann, F.; Hasenfuß, G.; Sandek, A.; Nolte, K.; Hashemi, D. & Trippel, T. D. et al. (2021)
ESC Heart Failure, 8(6) art. ehf2.13593. DOI: https://doi.org/10.1002/ehf2.13593
Details DOI
-
2021 | Journal Article
How family history of premature myocardial infarction affects patients at cardiovascular risk.
Nagel, J.; Chavanon, M.-L.; Binder, L.; Pieper, A.; Wachter, R.; Edelmann, F. & Herrmann-Lingen, C. (2021)
Health Psychology, 40(11) pp. 754-763. DOI: https://doi.org/10.1037/hea0001128
Details DOI
-
2021 | Journal Article |
Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
Schnelle, M.; Leha, A.; Eidizadeh, A.; Fuhlrott, K.; Trippel, T. D.; Hashemi, D. & Toischer, K. et al. (2021)
Cells, 10(10) pp. 2796. DOI: https://doi.org/10.3390/cells10102796
Details DOI